867333-26-4Relevant articles and documents
KINASE MODULATORS AND METHODS OF USE THEREOF
-
Page/Page column 148-149; 152, (2022/01/20)
The present invention relates to novel compounds that modulate the activity of one or more kinases, such as TYK2 or mutants thereof. The compounds, which may be kinase inhibitors or activators, are useful for treating autoimmune diseases, such as, such as psoriasis, lupus, multiple sclerosis, and inflammatory bowel disease.
Benzotriazine inhibitors of kinases
-
Page/Page column 115, (2008/06/13)
The invention provides benzotriazine compounds having formula (I). The benzotriazine compounds of the invention are capable of inhibiting kinases, such members of the Src kinase family, and various other specific receptor and non-receptor kinases.